Cargando…

Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen

OBJECTIVES: To describe the clinical characteristics and outcomes of adult macrophage activation syndrome (MAS) patients and to provide experience for the treatment. METHODS: Adult patients with MAS admitted to Beijing Friendship Hospital from December 2014 to September 2021 were enrolled in this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Lingbo, Yao, Shuyan, Zhang, Ruoxi, Liu, Menghan, Hua, Zhengjie, Zou, Heshan, Wang, Zhao, Wang, Yini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520258/ https://www.ncbi.nlm.nih.gov/pubmed/36189240 http://dx.doi.org/10.3389/fimmu.2022.955523

Ejemplares similares

Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients
por: Yao, Shuyan, et al.
Publicado: (2022)

Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
por: Yao, Shuyan, et al.
Publicado: (2021)

Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy
por: Hua, Zhengjie, et al.
Publicado: (2022)

A Study on Early Death Prognosis Model in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis
por: Zhang, Ruoxi, et al.
Publicado: (2022)

Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer
por: Kim, Yi Rang, et al.
Publicado: (2018)

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
por: Palmblad, Karin, et al.
Publicado: (2021)

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome
por: Henter, Jan-Inge, et al.
Publicado: (2011)

Editorial: Plasticity of monocytes/macrophages: phenotypic changes during disease progression
por: Yuan, Ruoxi, et al.
Publicado: (2023)

Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
por: Chen, Shunyao, et al.
Publicado: (2023)

Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis
por: Wang, Lin, et al.
Publicado: (2022)

Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia
por: Wang, Ming, et al.
Publicado: (2021)

The Notch signaling-regulated angiogenesis in rheumatoid arthritis: pathogenic mechanisms and therapeutic potentials
por: Zhao, Fang, et al.
Publicado: (2023)

Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis
por: Puliafito, Ivana, et al.
Publicado: (2023)

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
por: Sokolova, Alexandra, et al.
Publicado: (2017)

Macrophages in aseptic loosening: Characteristics, functions, and mechanisms
por: Cong, Yehao, et al.
Publicado: (2023)

Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
por: Colino, Clara I., et al.
Publicado: (2020)

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997)

Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
por: Ali, Arwa, et al.
Publicado: (2023)

Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation
por: Tazawa, Yuki, et al.
Publicado: (2016)

Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer
por: Hu, Qin, et al.
Publicado: (2022)

Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
por: Wang, Guoqing, et al.
Publicado: (2022)

Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets
por: Li, Yupei, et al.
Publicado: (2021)

The role of immunometabolism in macrophage polarization and its impact on acute lung injury/acute respiratory distress syndrome
por: Wang, Lian, et al.
Publicado: (2023)

The Immunology of Macrophage Activation Syndrome
por: Crayne, Courtney B., et al.
Publicado: (2019)

Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis
por: Wei, Liqiang, et al.
Publicado: (2020)

Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression
por: Cheng, Yanwei, et al.
Publicado: (2018)

Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity
por: Geeraerts, Xenia, et al.
Publicado: (2017)

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
por: van der Heide, Daphne, et al.
Publicado: (2019)

Vascular Macrophages as Therapeutic Targets to Treat Intracranial Aneurysms
por: Muhammad, Sajjad, et al.
Publicado: (2021)

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
por: Berghmans, Thierry, et al.
Publicado: (2017)

Polarized Macrophages in Periodontitis: Characteristics, Function, and Molecular Signaling
por: Sun, Xiaoyu, et al.
Publicado: (2021)

Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
por: Hu, Guorong, et al.
Publicado: (2019)

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens
por: Brunetti, Giacomina, et al.
Publicado: (2018)

Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
por: Feng, Yimei, et al.
Publicado: (2023)

Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases
por: Zhu, Jianshu, et al.
Publicado: (2023)

Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting
por: Singanayagam, Arjuna, et al.
Publicado: (2021)

A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals
por: Wang, Ke, et al.
Publicado: (2023)

Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_98f0pbq8aeki1q7pu804n15goh